By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adamas Pharmaceuticals 

1900 Powell Street
Suite 1050
Emeryville  California  94608  U.S.A.
Phone: 510-450-3500 Fax: 510-428-0519


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Adamas Pharmaceuticals (ADMS) To Present At 2015 Needham Healthcare Conference 4/10/2015 8:43:37 AM
Adamas Pharmaceuticals (ADMS) Receives Orphan Drug Designation For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia Associated With Parkinson's Disease 4/10/2015 8:36:46 AM
Adamas Pharmaceuticals (ADMS) Issued Patent 3/31/2015 2:29:02 PM
Adamas Pharmaceuticals (ADMS) Reports Fiscal 2014 Financial Results 3/4/2015 7:33:08 AM
Adamas Pharmaceuticals (ADMS) Phase 2/3 Clinical Study Published In Movement Disorders 2/10/2015 7:30:32 AM
Adamas Pharmaceuticals (ADMS) Provides Review Of 2014 And Previews Upcoming Business Drivers 1/12/2015 7:18:15 AM
Adamas Pharmaceuticals (ADMS) Receives $30 Million Milestone Payment From Actavis (ACT) 1/9/2015 7:23:19 AM
Actavis (ACT) and Adamas Pharmaceuticals (ADMS) Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride 12/24/2014 6:40:53 AM
Actavis (ACT), Adamas Pharmaceuticals (ADMS) Win FDA Approval for Alzheimer's Drug Namzaric 12/24/2014 6:39:42 AM
Adamas Pharmaceuticals (ADMS) Issued Six Additional U.S. Patents 12/4/2014 4:31:36 PM
12345
//-->